Search Results - "Bockisch, B."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease by Happel, C., Kranert, W. T., Gröner, D., Baumgarten, J., Halstenberg, J., Bockisch, B., Sabet, A., Grünwald, F.

    Published in Endocrine (2021)
    “…Aim Radioiodine therapy (RIT) may trigger the development of Graves’ ophthalmopathy (GO) or exacerbate pre-existing subclinical GO. Therefore, glucocorticoid…”
    Get full text
    Journal Article
  2. 2

    Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases by Happel, C., Kranert, W. T., Gröner, D., Bockisch, B., Sabet, A., Vardarli, I., Görges, R., Herrmann, K., Grünwald, F.

    Published in Endocrine (01-08-2020)
    “…Purpose Radioiodine-131 treatment has been a well-established therapy for benign thyroid diseases for more than 75 years. However, the physiological reasons of…”
    Get full text
    Journal Article
  3. 3

    Immobilized stem–loop structured probes as conformational switches for enzymatic detection of microbial 16S rRNA by Bockisch, Benjamin, Grunwald, Thomas, Spillner, Edzard, Bredehorst, Reinhard

    Published in Nucleic acids research (01-01-2005)
    “…We have designed and evaluated novel DNA stem–loop structured probes for enzymatic detection of nucleic acid targets. These probes constitute a novel class of…”
    Get full text
    Journal Article
  4. 4

    Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3) by Grunwald, Thomas, Bockisch, Benjamin, Spillner, Edzard, Ring, Johannes, Bredehorst, Reinhard, Ollert, Markus W.

    Published in Journal of Allergy and Clinical Immunology (01-04-2006)
    “…Acid phosphatase (Api m 3) is a major allergen in honeybee ( Apis mellifera) venom, and its availability as a recombinant protein may facilitate the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Incorporation monitoring of employees of a radioiodine therapy ward. Is incorporation monitoring required for routine? by Happel, C, Kratzel, U, Selkinski, I, Bockisch, B, Etzel, M, Korkusuz, H, Sauter, B, Staudt, J, von Müller, F, Grünwald, F, Kranert, W T

    Published in Nuclear medicine (2013)
    “…Aim of the study was to determine the annual incorporation of staff on a radioiodine therapy ward and the resulting annual effective dose (aed). Following the…”
    Get more information
    Journal Article
  7. 7

    Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131 I during radioiodine therapy of Graves' disease by Happel, C, Kranert, W T, Gröner, D, Baumgarten, J, Halstenberg, J, Bockisch, B, Sabet, A, Grünwald, F

    Published in Endocrine (13-01-2021)
    “…Radioiodine therapy (RIT) may trigger the development of Graves' ophthalmopathy (GO) or exacerbate pre-existing subclinical GO. Therefore, glucocorticoid…”
    Get full text
    Journal Article
  8. 8

    Colour-coded duplex-sonography versus scintigraphy. Can scintigraphy be replaced by sonography for diagnosis of functional thyroid autonomy? by Happel, C, Truong, P N, Bockisch, B, Zaplatnikov, K, Kranert, W T, Korkusuz, H, Ackermann, H, Grünwald, F

    Published in Nuclear medicine (2013)
    “…Since the development of colour coded duplex-sonography (ccds), several attempts have been made to implement this technique for diagnosis of focal lesions in…”
    Get more information
    Journal Article
  9. 9
  10. 10